Typically, intramuscular treatment for dietary vitamin B12 deficiency begins with a loading dose followed by maintenance therapy, contrasting with the steady daily doses used in oral treatment due to limited passive absorption
Symptoms Excruciating pain Difficulty in walking and standing for extended periods Worst pain in the morning upon rising and stepping out of bed Pain decreases with movement but can recur after long periods of standing or sitting Etiology Poorly understood cause Most common cause of heel pain Tension and stress on the fascia can cause small tears and inflammation Wear and tear from walking or running can result in degeneration of the fascia Heel spurs are a consequence, not the cause, of plantar fasciitis Risk Factors Age (between 40 and 60) High-impact exercises Flat feet or high arches Obesity Occupations that require prolonged standing or walking on hard surfaces Complications Ignoring plantar fasciitis can lead to chronic heel pain and affect overall posture Modifying walking or standing patterns due to pain can increase the risk of injury in other areas of the body Treatment Conservative treatment options are effective in 90% of cases Heel cups, night splints, orthotics, and shoe modifications OTC nonsteroidal anti-inflammatory medications Physical therapy and stretching exercises Platelet Rich Plasma (PRP) injections Extracorporeal Shockwave Therapy (ESWT) , a proven treatment with multiple clinical trials and meta-analyses showing its efficacy Conclusion ESWT has been shown to effectively treat plantar fasciitis and is also used in musculoskeletal medicine for various conditions
Individuals without a deficiency who wish to optimize their B12 levels may benefit from weekly or monthly injections, depending on their response to treatment
It usually takes a full skin cycle to see any results
In infrared, the storms look like fiery bouquets of roses: In this image, of Jupiters south pole, Juno is measuring the heat coming out of the depths of planet and through the clouds
There is currently no clinical data on the safety of combining BPC-157 and Retatrutide in humans
